In a statement Monday, the WHO said it was clearing the AstraZeneca vaccines made by the Serum Institute of India and South Korea's AstraZeneca-SKBio
WHO has granted an emergency authorization to AstraZeneca's Covid vaccine, a move that should allow the UN agency's partners to ship millions of doses to countries worldwide
South Africa has yet to launch its Covid-19 vaccination programme and the government has decided to go with the J&J dose
It's John Donne's foreboding in reverse: No matter for whom the bell tolls, it tolls for you and me
Pharmaceutical company AstraZeneca said it could take between six to nine months to produce Covid-19 vaccines that are effective against new variants of the virus
African countries without the coronavirus variant dominant in South Africa were encouraged go ahead and use the AstraZeneca Covid-19 vaccine
AstraZeneca said Thursday it's working with the University of Oxford to adapt its Covid-19 vaccine to protect against new strains of the virus
AstraZeneca's core business for diabetes, heart and kidney, and cancer medicines has proved resilient
The pharma company's Q4 sales beat expectations, profit in line and expects to report Covid-19 vaccine sales from Q1
The shot's effect in older people is expected to be the same as for younger recipients, said Alejandro Cravioto, chairman of the WHO panel, in a briefing
Vaccine delivery needs to move beyond govt control
South Africa delayed use of the vaccine after researchers found it offered minimal protection against mild-to-moderate Covid-19 disease caused by the country's dominant coronavirus variant
"We received 45,000 doses yesterday, the first 45,000 doses from AstraZeneca, and we expect more in the coming days," Themistokleous said
South Africa looks to J&J vaccine
Home-grown firms get new orders: 10 million for SII, 4.5 million for Bharat Bio
Drug firmAstraZeneca Pharma India on Monday reported a 21 per cent decline in net profit at Rs 21.05 crore for the quarter ended in December
Business Standard brings you top news of the evening
Prior to widespread circulation of the more contagious variant, the vaccine was showing efficacy of around 75%
The firm said it has received marketing authorisation to use its anti-diabetic drug dapagliflozin for the treatment of patients with chronic kidney disease
Company has started adapting vaccine against variant, shot may be ready by autumn this year